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Pancreatic and extrapancreatic galanin release 
during sympathetic neural activation 
BETH ELAINE DUNNING, PETER J. HAVEL, 
RICHARD C. VEITH, AND GERALD J. TABORSKY, JR. 
Division of Endocrinology and Metabolism and Geriatric Research Education and Clinical Center, 
Veterans Administration Medical Center, and Departments of Medicine and Psychiatry 
and Behavioral Sciences, University of Washington, Seattle, Washington 98195 
DUNNING, BETH ELAINE, PETER J. HAVEL, RICHARD C. 
VEITH, AND GERALD J. TABORSKY, JR. Pancreatic and extra- 
pancreatic galanin release during sympathetic neural activation. 
Am. J. Physiol. 258 (Endocrinol. Metab. 21): E436-E444, 
1990.-To address the hypothesis that the neutropeptide, gal- 
anin, functions as a sympathetic neurotransmitter in the en- 
docrine pancreas, we sought to determine if galanin is released 
from pancreatic sympathetic nerves during their direct electri- 
cal stimulation in halothane-anesthetized dogs. During bilat- 
eral thoracic splanchnic nerve stimulation (BTSNS), both pe- 
ripheral arterial and pancreatic venous levels of galanin-like 
immunoreactivity (GLIR) increased (A at 10 min = +92 t 31 
and +88 t 25 fmol/ml, respectively). Systemic infusions of 
synthetic galanin demonstrated that 1) the increment of arte- 
rial GLIR observed during BTSNS was sufficient to modestly 
restrain basal insulin secretion and 2) only 25% of any given 
increment of arterial GLIR appears in the pancreatic vein, 
suggesting that the pancreas extracts galanin, as it does other 
neurotransmitters. By use of 75% for pancreatic extraction of 
circulating galanin, it was calculated that pancreatic galanin 
spillover (output) increased by 410 t 110 fmol/min during 
BTSNS. To reinforce the conclusion that pancreatic sympa- 
thetic nerves release galanin, GLIR spillover was next measured 
during direct local stimulation of the pancreatic sympathetic 
input produced by electrical stimulation of the mixed auto- 
nomic pancreatic nerves (MPNS) in the presence of the gan- 
glionic blocker, hexamethonium. During this local pancreatic 
sympathetic nerve stimulation, arterial GLIR remained un- 
changed, but pancreatic venous GLIR increased by 123 t 34 
fmol/ml. Thus pancreatic GLIR spillover increased by 420 t 
110 fmol/min during MPNS in the presence of hexametho- 
nium. We conclude that galanin is released from both pan- 
creatic and extrapancreatic sources during sympathetic neural 
activation in dogs. 
sympathetic nervous system; insulin; glucagon; catecholamines 
IT HAS BEEN PROPOSED that the neuropeptide, galanin, 
acts as a sympathetic neurotransmitter in the enodcrine 
pancreas (9) and mediates the nonadrenergic inhibition 
of insulin (IRI) and stimulation of glucagon (IRG) secre- 
tion seen during activation of the sympathetic nervous 
system (3, 8). This hypothesis is based on evidence 
suggesting that 1) exogenous galanin qualitatively repro- 
duces the endocrine pancreatic effects of sympathetic 
activation (7, 17) and 2) galanin-like immunoreactivity 
(GLIR) is present in fibers innervating the islets of 
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Langerhans (7). Although the recent demonstration that 
GLIR spills over into the pancreatic venous effluent (i.e., 
is released) during electrical stimulation of the local 
mixed autonomic nerves of the pancreas (MPNS) in dogs 
(10) is consistent with the hypothesis, acceptance of 
galanin’s putative role as a sympathetic neurotransmitter 
awaits the further demonstration that it is released dur- 
ing sympathetic nerve stimulation. Because MPNS ac- 
tivates both postganglionic sympathetic and pregan- 
glionic parasympathetic fibers, the origin of GLIR re- 
leased during MPNS remains unclear. We therefore 
sought to test directly the hypothesis that galanin is a 
sympathetic neurotransmitter in the pancreas by deter- 
mining whether pancreatic galanin is released by sym- 
pathetic nerves. 
In the present study we measured pancreatic spillover 
and peripheral levels of both GLIR and norepinephrine 
(NE) in halothane-anesthetized dogs during 1) general- 
ized sympathetic activation produced by bilateral tho- 
racic splanchnic nerve stimulation (BTSNS) and 2) se- 
lective activation of the local sympathetic input to the 
pancreas (MPNS in the presence of the ganglionic 
blocker, hexamethonium). In addition, we quantified 
pancreatic extraction of infused galanin (reflecting a 
potential local mechanism to terminate this putative 
neurotransmitter’s action). Finally, we examined 
whether sufficient galanin is present in the systemic 
circulation during generalized sympathetic activation 
(BTSNS) to influence IRI secretion hormonally. 
MATERIALS AND METHODS 
Animals and surgical procedures. Anesthesia was in- 
duced with the ultrashort-acting barbiturate, thiamylal 
sodium (Surital, Parke Davis, Morris Plains, NJ, 30 mg/ 
kg iv) in adult dogs of mixed breed (19-37 kg) following 
an overnight fast (-18 h). Anesthesia was subsequently 
maintained with halothane (0.8%) administered from a 
calibrated vaporizer (Draeger, FRG) by mechanical ven- 
tilation in 100% oxygen. To access the pancreatic venous 
blood, a laparotomy was performed and an extracorporeal 
shunt containing a sampling port and an electromagnetic 
flow probe (Zepeda Instruments, Seattle, WA) was placed 
between the superior pancreaticoduodenal vein (SPDV) 
and the portal vein. A femoral artery (FA) and vein were 
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cannulated for arterial blood sampling and intravenous 
infusions of saline or galanin. 
To stimulate the thoracic splanchnic nerves, bilateral 
thoracotomies were performed at the seventh intercostal 
space. The sympathetic trunks were dissected from sur- 
rounding tissue along the dorsal rib cage, and bipolar 
electrodes (Harvard Apparatus, South Natick, MA) were 
placed on each nerve at the level of approximately Tlo. 
The nerve trunks were then severed anterior to the 
electrodes. In dogs in which the mixed autonomic pan- 
creatic nerves were stimulated, the nerve fibers along the 
superior pancreaticoduodenal artery were dissected free 
from the artery along with the adjacent fascia and placed 
in a bipolar electrode. A 60-min stabilization period 
followed the surgical procedures before experimentation. 
Experimental protocols. To determine whether galanin 
is released during stimulation of the thoracic splanchnic 
nerves (BTSNS), the sympathetic trunks were electri- 
cally stimulated for 10 min with square wave pulses of 
I-ms duration and 10 mA current at a frequency of 8 Hz. 
The stimulations were performed with a model S-44 
stimulator coupled to a PSIUG stimulus isolation unit 
(Grass Instruments, Quincy, MA). Stimulation parame- 
ters were monitored with an oscilloscope. To allow meas- 
urement of pancreatic neurotransmitter spillover and 
hormone output, paired base-line blood samples were 
drawn from the FA and the SPDV at 10 and 0 min 
before, 2.55, and 10 min during, and 5 and 15 min after 
BTSNS. 
To determine the rate of extraction of galanin across 
the pancreas, synthetic porcine galanin (Bachem, Torr- 
ance, CA) was infused for 30 min in 14 dogs via the 
femoral vein at rates ranging from 1.3 to 26 pmol l kg-’ l 
min? GLIR was measured in samples obtained simul- 
taneously from the FA and the SPDV, before (-10 and 
0 min), during (5, 10, 20, and 30 min), and after (5 and 
15 min) galanin infusions. Pancreatic galanin extraction 
was defined as (A[GLIR]FA - A[GLIR]sn&A[GLIR]FA. 
In six of these dogs receiving the lowest dose (1.3 pmol 
kg-‘. min-‘) samples were also obtained for measurement 
of pancreatic hormones and glucose to determine the 
effects of low-dose galanin infusions on islet function 
(see RESULTS, Fig. 8). 
To determine if galanin is released from pancreatic 
nerves during selective local sympathetic neural activa- 
tion, MPNS was performed in the presence of the gan- 
glionic blocker, hexamethonium (HEX). Hexametho- 
nium bromide (Sigma Chemical, St. Louis, MO) was 
injected intravenously in repeated doses of 0.1 mg/kg, 
until the mean arterial blood pressure dropped by lo-20 
mmHg and remained at that lower level. HEX was then 
infused at a rate of 0.7 pg* kg-’ l min-’ times the number 
of doses injected initially. This dosage has previously 
been shown to eliminate all pancreatic effects of vagal 
nerve stimulation (2). The mixed autonomic pancreatic 
nerves running in the arterial sheath (see above) were 
then stimulated with the same stimulation parameters 
and sampling times employed for BTSNS. 
In all experiments, mean arterial blood pressure and 
SPDV blood flow were monitored continuously and hem- 
atocrit was determined at regular intervals. 
Sample handling and chemical determinations. Blood 
samples for measurement of GLIR were immediately 
placed in tubes containing a mixture of proteolytic en- 
zyme inhibitors (5). Samples for catecholamine determi- 
nations were placed in tubes containing glutathione and 
ethylene glycol-bis(P-aminoethyl ether)-N,N,N’,N’-te- 
traactic acid, those for insulin (IRI) and glucose meas- 
urements were placed in tubes containing EDTA, and 
those for glucagon (IRG) measurements were placed in 
tubes containing heparin and benzamidine. All blood 
samples were kept on ice (~2 h), centrifuged, and stored 
at -20°C until assay. 
GLIR was measured in unextracted plasma by radio- 
immunoassay (RIA) with a non-COOH-terminally di- 
rected antibody raised against synthetic porcine galanin 
and synthetic porcine galanin standards by a procedure 
described previously (10). Because the species variable 
portion of the galanin molecule is apparently limited to 
the COOH-terminal heptapeptide (14, 19), this assay 
detects GLIR from all species yet examined. Over 90% 
of synthetic galanin added to dog plasma is recovered in 
a single peak upon gel filtration. 
Plasma NE and epinephrine (EPI) were measured with 
a sensitive and specific radioenzymatic assay (18). IRI 
and IRG were measured by RIA with methods described 
previously (21) and glucose was measured by a glucose 
oxidase method. 
Chromatography. To determine the molecular forms of 
GLIR present in arterial plasma in the basal and stim- 
ulated states, additional plasma samples were obtained 
before (time 0) and during (7.5 min) BTSNS in three 
dogs. Plasma samples (1.5 ml) were applied to a 1 X 50- 
cm column of Sephadex G-50 and eluted with galanin 
assay buffer. Sixty l-ml fractions were collected for gal- 
anin RIA. 
Data analysis. Pancreatic hormone output was calcu- 
lated according to the following formula: output = ([hor- 
mone] SPDV - [hormone]& x (l- hematocrit) X blood 
flowspDV. Pancreatic neurotransmitter spillover (synon- 
ymous with output) was calculated using the same prin- 
ciple but with equations modified to take into account 
the extraction of circulating neurotransmitters by the 
pancreas. Because both NE (1) and galanin (see RE- 
SULTS) are extracted by the pancreas, most of the trans- 
mitter arriving via the arterial circulation does not ap- 
pear in the pancreatic vein and therefore simple arteri- 
ovenous (AV) concentration difference measurements 
seriously underestimate pancreatic neurotransmitter re- 
lease. To correct the AV difference for extraction, neu- 
rotransmitter spillover was calculated as follows: spill- 
over = {[NE or GLIR]spnv - (arterial contribution to 
SPDV level)} x (1 - hematocrit) X blood flowspnv. The 
arterial contribution to SPDV level is defined to be the 
amount of neurotransmitter present in the SPDV plasma 
that arrives via the arterial circulation but escapes pan- 
creatic extraction. Because EPI is extracted at the same 
rate as NE (l), EPI extraction was used as an index of 
NE extraction and employed to calculate the arterial 
contribution to SPDV [NE]. Thus the arterial contri- 
bution to SPDV [NE] = [NE]FA x (1 - pancreatic EPI 
extraction), where EPI extraction is defined to be 
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FIG. 1. Pancreatic venous (SPDV, A) and femoral arterial (FA, B) 
levels of galanin-like immunoreactivity (GLIR) during lo-min bilateral 
thoracic splanchnic nerve stimulation (BTSNS) in dogs. Values are 
means t SE, n = 6. 
([EPIIFA - [EPI]sPDv)/[EPI] FA. In the case of galanin, 
in the basal state, nearly all plasma GLIR represents a 
large-molecular-weight cross-reactant in the RIA (10). It 
is present in equal amounts in FA and SPDV plasma 
and thus does not appear to be subject to pancreatic 
extraction (see RESULTS, Fig. 2, and DISCUSSION). There- 
fore, only the increment over the basal FA level was 
considered to be true galanin and used in the extraction- 
spillover calculation. Pancreatic extraction of exoge- 
nously infused galanin was measured directly (see above), 
found to be 75% (see RESULTS), and assumed to be 
Synthetic 
Galanin 
constant and equivalent to the pancreatic extraction of 
endogenous “true” galanin. Thus, when FA levels of 
GLIR increased during BTSNS, pancreatic galanin spill- 
over was calculated as follows: spillover = ([ GLIR]sPnv 
- ([GLIR]b,dFA -i- 0.25 ([GLIRIFA - [GLIR]b,,oA)]) x 
(1 - hematocrit) X blood flowspnv where [GLIR]b,,,l FA 
was defined as the mean of the FA levels at -10 and 0 
min (before BTSNS). 
During MPNS in the presence of HEX, FA levels of 
GLIR did not increase, and therefore the complex cal- 
culation for GLIR spillover reduces to that used for 
hormone output. Similarly, because SPDV levels of NE 
vastly exceeded arterial NE levels during these local 
nerve stimulations, the calculation for pancreatic NE 
spillover also reduces to that used for hormone output. 
All data were expressed as means t SE. Statistical 
comparisons of means within a group at different times 
were made with a paired t test at the time point indicated 
in the text. Comparisons of means between groups were 
made with a two-sample t test. 
RESULTS 
Splanchnic nerve stimulations. Figure 1 depicts the 
levels of GLIR in unextracted plasma obtained from the 
SPDV and FA during electrical BTSNS in halothane- 
anesthetized dogs. Pancreatic venous GLIR (Fig. lA) 
increased rapidly during BTSNS from a base line of 82 
t 18 fmol/ml to 147 t 16 at 5 min and to 170 t 27 at 10 
min (A at 10 min = +88 t 25 fmol/ml, n = 6, P < O.Ol), 
then returned to base line (88 t 17 fmol/ml) 15 min after 
the nerve stimulation. Arterial levels of GLIR (Fig. 1B) 
also increased during BTSNS from a base line of 69 t 
13 fmol/ml to 114 t 21 at 5 min and to 162 t 31 at 10 
min (A at 10 min = +92 t 31 fmol/ml, PC 0.025), and 
returned to base line (78 t 17) 15 min after BTSNS. 
Previous studies have demonstrated that the incre- 
ment of GLIR in SPDV plasma during local autonomic 
nerve stimulation coeluted with synthetic galanin (10). 
40 
n=3 FIG. 2. Elution profile after gel filtra- 
tion on Sephadex G-50 of galanin-like 
immunoreactivity (GLIR) in femoral ar- 
terial plasma before (basal) and during 
lo-min bilateral thoracic splanchnic 
nerve stimulation (BTSNS) in dogs. 
Ve/Vo, ratio of elution position to void 
volume. Elution position of synthetic 
porcine galanin is indicated by arrow. 
Values are means 2 SE of 3 experiments. 
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FIG. 3. Plasma concentrations of norepinephrine (NE, A) and epi- 
nephrine (EPI, B) in pancreatic vein (SPDV) and femoral artery (FA) 
and pancreatic NE spillover (C) before (time 0) and at 5 and 10 min 
during bilateral thoracic splanchnic nerve stimulation in dogs. Values 
are means + SE, n = 6. 
To determine whether the increment of GLIR in arterial 
plasma observed during BTSNS was also caused by an 
increase of a galanin-sized molecule, gel filtration of 
arterial plasma was performed. Figure 2 depicts the Seph- 
adex G-50 gel filtration profile of GLIR present in FA 
plasma before (basal) and during BTSNS. In the basal 
state, there was one peak of GLIR, eluting in the void 
volume (V,). During BTSNS, FA plasma contained two 
peaks of GLIR, one (V,) peak nearly identical to that in 
basal plasma and a second (V,/V, = 1.8-2.3) that coe- 
luted with synthetic porcine galanin. Thus there is little 
galanin-sized GLIR in basal FA plasma, but the entire 
increment over basal measured during BTSNS repre- 
sents a species with an elution position characteristic of 
galanin. 
Figure 3 illustrates the catecholamine levels and NE 
spillover that occurred before (t = 0 min) and during (t 
= 5 and 10 min) BTSNS. As seen in Fig. 3A, FA NE 
levels were similar to SPDV NE levels both before and 
during BTSNS, analogous to the GLIR data (see Fig. 1). 
BTSNS increased FA and SPDV levels of NE by 620 & 
280 and 660 f 210 pg/ml, respectively. As shown in Fig. 
323, however, the increases of FA and SPDV EPI levels 
were not equivalent. BTSNS markedly increased FA EPI 
(A at 10 min = +960 + 360 pg/ml), presumably because 
of activation of the adrenal medulla. BTSNS also in- 
creased SPDV EPI (A at 10 min = +240 + 100 pg/ml) 
but to a much smaller extent than it increased FA EPI, 
reflecting pancreatic extraction of EPI. Because the pan- 
creatic nerves release little EPI and because pancreatic 
extraction of EPI is known to be very similar to that of 
NE (l), EPI extraction could be used as an index of NE 
extraction. By this means (see MATERIALS AND METH- 
ODS), pancreatic NE spillover was calculated. As shown 
in Fig. 3C, NE spillover increased during BTSNS from 
a base line of 180 + 120 to 3,260 + 790 pg/min at 10 min 
(A = +3,080 + 770 pg/min = 18 rf: 5 pmol/min, n = 6, P 
< 0.01). 
Table 1 reports the maximum changes of pancreatic 
output of insulin (IRI) and glucagon (IRG) , of FA glucose 
levels, mean arterial blood pressure, SPDV blood flow, 
and hematocrit that occurred during BTSNS, together 
with the time at which the maximum change occurred. 
Consistent with sympathetic activation, IRI output was 
rapdily inhibited and that of IRG was stimulatd. Glucose 
levels changed little early in the BTSNS (AFA glucose 
at 2.5 min = +8 + 2 mg/dl, data not shown) but increased 
markedly (+75 mg/dl) by the 10th min of BTSNS. 
Therefore, the net stimulation of IRI output that oc- 
curred by the end of BTSNS (A at 10 min = +250 + 
120%) actually represents a relative inhibition, as ap- 
posed to the absolute inhibition that occurred earlier, 
before hyperglycemia. BTSNS also increased blood pres- 
sure, hematocrit, and SPDV blood flow. 
Because FA levels of GLIR increased during BTSNS, 
it was unclear how much of the increase of SPDV GLIR 
was caused by the increase of circulating GLIR and how 
much was attributable to local pancreatic neural release 
of galanin. Thus it was necessary to determine the rate 
at which the pancreas extracts galanin (analogous to 
extraction of EPI, Fig. 3B) to calculate neuronal spillover 
of GLIR. Therefore, synthetic galanin was infused sys- 
temically at a range of doses, and GLIR was measured 
in plasma samples obtained simultaneously from the FA 
and the SPDV. As shown in Fig. 4, there was a linear 
TABLE 1. Effects of bilateral thoracic splanchnic nerve stimulation 
Parameter Maximum Change Time, min PC 
AIR1 output, gU/min (%) -760f180 (-45+9) 2.5 0.005 
+1,450+1,010 (+250+120) 10 NS 
AIRG output, pg/min (%) +960+310 (+320+110) 5 0.05 
AGlucose, mg/dl +75+21 10 0.02 
AMAP, mmHg +30+10 2.5 0.05 
APancreatic blood flow, ml/min +4.2+1.5 2.5 0.05 
AHematocrit, % +6.3+2.2 10 0.05 
Values are means + SE; n = 6 dogs. Immunoreactive insulin (IRI) and glucagon (IRG); MAP, mean arterial pressure; NS, not significant. 
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relationship between the increment of arterial GLIR 
(AFA GLIR) resulting from the intravenous infusions 
and the much smaller increment of pancreatic venous 
GLIR (ASPDV GLIR). As reflected by the slope of this 
line, for any given increment of FA, GLIR, only 25% of 
that increment appeared in SPDV plasma. This relation- 
ship was constant over the wide range of galanin concen- 
trations, which included six that were in the range of 
those measured during BTSNS. The slope of the corre- 
lation between AFA and ASPDV GLIR represents one 
minus the mean extraction of galanin during the 14 
infusions; pancreatic extraction of galanin was 75%. 
Because only the increment of FA GLIR during 
BTSNS is likely to be galanin (Fig. Z), the value of 75% 
extraction was applied only to that increment when 
calculating (see MATERIALS AND METHODS) GLIR spill- 
over. Figure 5 depicts the calculated net pancreatic spill- 
over of GLIR during BTSNS. GLIR spillover increased 
during BTSNS from a base line of 70 t 50 fmol/min to 
370 t 60 at 5 min and to 470 t 120 fmol/min at 10 min 
(A at 10 min = +410 t 110 fmol/min, n = 6, P < O.Ol), 
then returned to base line (100 t 50 fmol/min) 15 min 
after the stimulation was teminated. 
Pancreatic nerve stimulations during ganglionic block- 
ade. Because of the complex calculations and assump- 
tions involved in determining pancreatic galanin spill- 
over during BTSNS, we sought a second, independent 
test of the hypothesis that galanin is released from the 
sympathetic nerves of the pancreas. Therfore, GLIR 
spillover was also measured during the selective activa- 
tion of the pancreatic sympathetic nerves produced by 
local MPNS in the presence of the ganglionic blocker, 
HEX. Figure 6 depicts SPDV and FA levels of GLIR, 
SPDV blood flow, and pancreatic spillover of GLIR 
during these experiments. Pancreatic venous levels of 
GLIR increased rapidly and markedly during MPNS in 
the presence of HEX (Fig. 6A) from a base line of 84 t 
30 fmol/ml to 208 t 55 at 5 min and to 187 t 48 fmol/ 
ml at 10 min (A at 5 min = +123 t 34 fmol/ml, n = 6, P 
< O.Ol), then returned to base line (78 t 15 fmol/ml) 15 
min after the nerve stimulation. In contrast, FA GLIR 
did not change significantly from base line (61 t 11 
800- 
Y= 0.25x + 8.0 R= 0.96 
0 
0 1ooo 2ooo 3ooo 
A FA GLIR 
-20 -10 0 IO 20 30 
Time (min) 
FIG. 4. Change of femoral arterial (FA) vs. pancreatic venous FIG. 6. Pancreatic venous (SPDV) and femoral arterial (FA) levels 
(SPDV) levels (fmol/ml) of galanin-like immunoreactivity (GLIR) of galanin-like immunoreactivity (GLIR, A), SPDV blood flow (B), 
during 14 intravenous infusions of synthetic porcine galanin at rates and calculated pancreatic spillover of GLIR (C) during local sympa- 
varying from 1.3 to 26 mol l kg-’ l min-’ in anesthetized dogs. Equation thetic nerve stimulation elicited by mixed autonomic pancreatic nerve 
for regression line best fitted to these points is shown. Slope of this stimulation (MPNS) in presence of ganglionic blocker, hexamethonium 
line renresents 1 mean nancreatic galanin extraction. (HEX). in does. Values are means I~I SE. n = 6. 
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FIG. 5. Calculated pancreatic spillover of galanin-like immunoreac- 
tivity (GLIR) during bilateral thoracic splanchnic nerve stimulation 
(BTSNS) in dogs. Values are means t SE, n = 6. 
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fmol/ml) during the local sympathetic nerve stimulation. 
Pancreatic venous blood flow decreased during MPNS 
in the presence of HEX, from a base line of 8.0 + 1.5 
ml/min to a nadir at 2.5 min of 6.2 + 1.4 ml/min (A at 
2.5 min = -1.8 + 0.7 ml/min, P < 0.025) but returned 
toward base line by the 10th min of MPNS (7.3 + 2.0 
ml/min). Thus, as shown in Fig. 6C, net spillover in- 
creased from a base line of 90 f 80 fmol/min to 490 -C 
90 at 5 min and to 510 + 80 at 10 min during the nerve 
stimulation (A at 10 min = +420 rt 110 fmol/min, P < 
0.01) and returned to base line (80 + 40 fmol/min) 15 
min after termination of the MPNS. 
Figure 7 shows plasma catecholamine levels in the 
SPDV and FA during the MPNS in the presence of 
HEX, together with the net pancreatic spillover of NE. 
As depicted in Fig. 7B, SPDV NE increased during 
MPNS from a base line of 60 + 10 pg/ml to 2,940 rf: 860 
at 5 min and to 2,280 rt 630 pg/ml at 10 min (A at 10 
min = +2,210 + 630 pg/ml, n = 6, P < O.Ol), whereas 
0 
Time~min) 
10 
lm-B 
q PA 
n SPDV 
500- 
0 
Tirne~min) 
10 
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FIG. 7. Plasma concentration of norepinephrine (NE, A) and epi- 
nephrine (EPI, B) in pancreatic vein (SPDV) and femoral artery (FA) 
and pancreatic spillover of NE (C) before (time 0) and at 5 and 10 min 
during mixed pancreatic nerve stimulation in presence of hexametho- 
nium. Values are means rt SE, n = 6. 
FA NE levels did not change significantly from the base 
line of 80 f 20 pg/ml. As shown in Fig. 7B, SPDV levels 
of EPI increased modestly during MPNS in the presence 
of HEX from a base line of 40 + 10 to 210 + 50 at 5 min 
and to 180 + 40 at 10 min (A at 10 min = +140 + 30 pg/ 
ml, P < 0.005), and FA EPI levels did not change signif- 
icantly from the base line of 70 + 10 pg/ml. Figure 7C 
depicts net pancreatic spillover of NE that occurred 
during MPNS in the presence of HEX. NE spillover 
increased markedly from a base line of 10 + 100 to 8,920 
+ 2,640 at 5 min and to 6,950 + 2,050 pg/min at 10 min 
during MPNS (A at 10 min = +6,930 + 2,080 pg/min = 
+41 + 12 pmol/min, n = 6, P < 0.025). 
Potential hormonal actions of galunin. To determine if 
the increase of arterial GLIR that occurred during 
BTSNS (see Figs. 1 and 2) might influence pancreatic 
hormone secretion, synthetic galanin was infused sys- 
temically at a rate chosen to reproduce the increment of 
FA GLIR that occurred during BTSNS. Figure 8 illus- 
trates the changes of FA GLIR, IRI output, and FA 
glucose during systemic infusion of galanin at a rate of 
1.3 pmol + kg-‘. min-‘. As shown in Fig. 8A, FA GLIR 
loo- 
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FIG. 8. Change of femoral arterial (FA) galanin-like immunoreac- 
tivity (GLIR), insulin (IRI) output, and FA glucose during 30-min 
intravenous infusions of synthetic porcine galanin at rate of 1.3 pmol. 
kg-‘. min-‘. Values are means + SE, n = 6. 
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increased during systemic galanin infusion from a base 
line of 65 t 18 fmol/ml to a mean over the 30-min 
infusion of 169 t 14 fmol/ml (A = +84 t 21 fmol/ml, n 
= 6, P < O.Ol), then returned nearly to base line (84 t 
21 fmol/ml) 5 min after terminating the infusion. This 
increment of FA GLIR was very similar to that measured 
during BTSNS (+92 t 31 fmol/min, see Fig. 1). As shown 
in Fig. 8B, basal IRI output from the duodenal lobe of 
the dog pancreas decreased modestly during systemic 
galanin infusion from a base line of 1,000 t 230 pU/min 
to a nadir at 10 min of 685 t 220 pU/min (A at 10 min 
= -320 t 140 pU/min = -31 t 9%, P c 0.01). IRI 
output recovered above base line at 30 min during the 
infusion (A at 30 min = +380 t 370 pU/min, P = NS). 
Figure 8C depicts the change of glucose levels that oc- 
curred during systemic galanin infusion. Glucose levels 
increased from a base line of 96 t 9 mg/dl to a peak at 
30 min of 106 t 11 mg/dl (A at 30 min = +10 t 3 mg/ 
dl, P < 0.025) and returned toward base line (103 t 12 
mg/dl) 15 min after the infusion. Glucagon output did 
not change significantly during the systemic galanin 
infusion (data not shown). 
DISCUSSION 
The 29-amino acid peptide, galanin, has been shown 
previously to meet several of the criteria necessary to be 
considered a sympathetic neurotransmitter in the endo- 
crine pancreas (9). Earlier findings that the effects of 
sympathetic neural activation on basal pancreatic hor- 
mone secretion cannot be explained solely by the actions 
of NE (3, 8) lent import to the question of whether 
galanin is released from pancreatic sympathetic nerves. 
The present study was initiated to address this question 
by measuring the pancreatic spillover of GLIR and NE 
during sympathetic neural activation produced by two 
independent experimental methods. 
The first approach was to selectively activate pregan- 
glionic sympathetic fibers by electrically stimulating the 
thoracic splanchnic nerves at the level of Tlo. During 
this BTSNS, arterial (FA) and pancreatic venous 
(SPDV) levels of both GLIR and NE increased rapidly 
and markedly. Because the magnitude of the increases 
in the FA and SPDV were very similar (in each case) it 
might be concluded erroneously that neither NE nor 
GLIR was released from pancreatic nerves. However, we 
have previously shown that the pancreas avidly extracts 
NE (1). Thus the majority of NE in arterial plasma does 
not contribute to NE concentrations in the pancreatic 
venous effluent and therefore most of the increment of 
SPDV NE represents NE of pancreatic origin. Because 
pancreatic fractional extraction of EPI is very similar to 
that of NE (1), but the pancreatic nerves usually release 
little EPI, pancreatic extraction of EPI can be used as 
an ongoing index of NE extraction when the arterial 
[EPI] is high. By means of this index of NE extraction, 
net pancreatic spillover of NE was found to increase 
during BTSNS, by ~18 pmol/min, despite the lack of an 
AV [NE] difference across the pancreas. With a more 
direct measure of pancreatic NE extraction, the AV 
difference of infused [3H]NE, we have previously re- 
ported that BTSNS produces a very similar increase 
(+16 pmol/min) of calculated pancreatic NE spillover 
(12) 
As was the case for NE, both SPDV and FA levels of 
GLIR increased during BTSNS. However, we had no 
ongoing index of galanin extraction to employ for cal- 
culation of GLIR spillover in these experiments. There- 
fore, it was necessary to assess pancreatic galanin ex- 
traction in separate experiments by use of exogenous 
galanin infusions in the absence of changes of endoge- 
nous galanin. Doing so, we found that the pancreas 
extracts GLIR, as it does NE, at a high and constant 
rate. Measuring simultaneous changes of FA and SPDV 
GLIR levels during systemic galanin infusion, we found 
that the pancreas extracts 75% of the circulating GLIR 
in one pass. This value is very similar to that previously 
reported for NE (1) and that we found for EPI (74 t 4%) 
in the present experiments. 
Although it is now accepted that an adrenergically 
innervated organ extracts catecholamines, presumably 
by a combination of the well-described neuronal reuptake 
(uptake 1) and tissue uptake (uptake 2) (13), initially we 
found it surprising that the pancreas so avidly extracts 
a peptide neurotransmitter. However, the mechanism of 
galanin extraction remains to be determined. It is pos- 
sible, although unlikely, that there exists a mechanism 
for peptide recycling by the nerve terminals, analogous 
to uptake 1 for NE. It would seem more likely that 
pancreatic galanin extraction occurs by binding to spe- 
cific receptors on the target organ (as have been described 
recently on an insulin-secreting cell line; Ref. 16) and 
either internalization or degradation into nonimmuno- 
reactive and presumably nonbioactive forms. The finding 
that galanin is extracted by the pancreas suggests the 
existence of a mechanism to rapidly inactivate neurally 
released galanin, keeping its effects local. That there 
exists such a local mechanism for terminating galanin 
actions suggests that galanin meets another criterion to 
be considered a neurotransmitter in the endocrine pan- 
creas. Indeed, this criterion is not often considered in 
the context of a peptide neurotransmitter, but it is one 
that has historically been set forth for classical neuro- 
transmitters such as NE and acetylcholine. 
Having established that the pancreas extracts syn- 
thetic galanin and that the increment of arterial GLIR 
that occurs during BTSNS coelutes with synthetic gal- 
anin, we assumed that the endogenous circulating GLIR 
was s ubject to the same pancreatic extraction. Therefore 
we employed the measured value for extraction (75%) to 
calculate net pancreatic spillover of GLIR during 
BTSNS. It was thus determined that there is little net 
GLIR spillover in the basal state but that pancreatic 
GLIR spillover increased markedly during the general 
sympathetic neural activation produced by BTSNS. In 
light of the pancreatic GLIR release during sympathetic 
activation, it may be concluded that some and possibly 
all of the pancreatic “galanergic” nerves are sympathetic. 
During BTSNS, IRG secretion was enhanced and IRI 
output was inhibited; initially there was an absolute 
decrease below base line, and later insulin secretion was 
restrained relative to the ongoing hyperglycemia. The 
known potency of galanin to inhibit basal IRI secretion 
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(7) and the lack of effect of NE by itself to inhibit basal 
IRI secretion in vivo in dogs (3) suggest that the neurally 
released galanin could play a primary role in mediating 
the early inhibition of basal IRI output that occurred 
during BTSNS, even though the magnitude of GLIR 
spillover observed during BTSNS (+410 fmol/min) was 
only 2.5% of that of NE on a molar basis. It must be 
allowed, however, that the changes of pancreatic hor- 
mone secretion induced by BTSNS are unlikely to be 
mediated by a single factor. Rather, they probably reflect 
the net effect of several mediators capable of influencing 
the endocrine pancreas, including both a- and ,&adre- 
nergic effects of the circulating EPI and NE, locally 
released NE, direct effects of glucose, insulin-inhibiting 
and glucagon-stimulating effects of locally released gal- 
anin, and possibly even 
galan in (see below ,) . 
modest effects of the circulating 
Although the experiments discussed thus far suggest 
that galanin is released from pancreatic sympathetic 
nerves, and may play a role in mediation of the islet 
response, we sought to reinforce this conclusion with a 
second approach because the determination of net pan- 
creatic galanin spillover during BTSNS necessitated the 
use of rather complex calculations and assumptions. 
Therefore, GLIR spillover was also measured during 
MPNS in the presence of HEX. This ganglionic blocker 
was emp 
ously to 
II .oyed in a pro tocol that h .as been shown previ- 
elimi .nate all endocrine Pa ncreatic effects of 
direct electrical stimulation of the thoracic vagal nerves 
(2) and that would therefore be expected to block the 
intrapancreatic ganglionic transmission of impulses gen- 
erated by activating preganglionic parasympathetic fi- 
bers coursing with the sympathetic fibers in the pan- 
creatic arterial sheath. 
Because this local sympathetic nerve stimulation did 
not raise arterial levels of NE or GLIR, calculation of 
increases of net spillover did not require estimation of 
the contribution of arterial NE or galanin to that meas- 
ured in the SPDV. With this simpler calculation of 
neurotransmitter output, MPNS in the presence of HEX 
was found to increase pancreatic spillover of both NE 
and GLIR. The increment of GLIR spillover observed 
during MPNS in the presence of HEX was nearly iden- 
tical to that found to occur during BTSNS. Interestingly, 
the increment of NE that occurred during MPNS in the 
presence of HEX was nearly threefold the increment 
observed during BTSNS. Therefore, the molar ratio of 
NE to galanin released during MPNS in the presence of 
HEX was slightly X00:1. This ratio is quite similar to 
that we found previously to occur during MPNS in the 
absence of HEX (10). 
The finding that MPNS in the presence of HEX 
releases more NE than does BTSNS, but that the two 
modes of sympathetic activation release the same 
amount of GLIR, allows for some limited speculation 
regarding the nature of the pancreatic sympathetic in- 
nervation. Specifically, it suggests that not all pancreatic 
noradrenergic nerves contain galanin. However, colocal- 
ization of galanin and NE in a subpopulation of norad- 
renergic nerves remains a viable possibility. In addition, 
it would appear that all preganglionic input to pancreatic 
galanergic nerves arises above the level of the present 
BTSNS, and thus is activated by BTSNS, whereas ad- 
ditional NE-containing nerves arise below the level of 
the BTSNS and are activated only during MPNS. 
Clearly, it will take both immunocytochemical and fur- 
ther electrophysiological studies to corroborate such 
speculation. 
The present observation, that two different modes of 
sympathetic neural activation elicited GLIR spillover 
into the pancreatic venous effluent, suggests that the 
pancreatic galanergic nerves are extrinsic, postganglionic 
sympathetic fibers. This is consistent with our earlier 
studies in which we found galanin-containing fibers in- 
nervating dog islets, but no cell bodies in the pancreas 
containing galanin-like immunoreactivity (7). This clas- 
sification of galanin nerves is also consistent with a 
recent description by Kummer (15), of dense galanin 
staining in cell bodies of paravertebral sympathetic gan- 
glia in cats. Interestingly, in that report, many of the 
galanin cells also contained neuropeptide Y (NPY). Be- 
cause dog islets also contain NPY-positive fibers (6), it 
would be of interest to determine if these two peptides 
coexist in pancreatic sympathetic nerves. In apparent 
contrast to the galanin-staining studies in dogs and to 
the present data demonstrating galanin release during 
sympathetic neural activation, Su et al. (20) suggest that 
the few galanergic nerves in rat islets are exclusively 
intrinsic. These differences remain unresolved but are 
likely to represent species differences in pancreatic gal- 
anergic innervation. 
Returning briefly to the generalized sympathetic acti- 
vation produced by BTSNS, the unexpected increase of 
circulating GLIR that occurred raised two additional 
questions. The first issue, the origin of the arterial GLIR, 
was not addressed directly in this study. However, be- 
cause an equivalent increase of pancreatic spillover of 
GLIR occured during BTSNS and local sympathetic 
stimulation but the local MPNS during HEX did not 
raise circulating GLIR, it is unlikely that pancreatic 
GLIR could make, a significant contribution to the cir- 
culating GLIR measured during BTSNS. Therefore, it 
appears that generalized sympathetic activation induced 
by BTSNS released galanin from extrapancreatic as well 
as pancreatic sources. Because 1) galanin-immunoreac- 
tive nerves are present throughout the gastrointestinal 
(GI) tract of several mammalian species including the 
dog (11, 20), 2) we have found significant amounts of 
GLIR in extracts of various portions of the canine GI 
tract (unpublished observations), and 3) BTSNS would 
be expected to activate sympathetic nerves of the entire 
splanchnic bed, it is possible that enough galanin would 
be released from the GI tract during BTSNS to account 
for the increase of peripheral levels. It may also be 
postulated that the circulating galanin derived at least 
in part from the adrenal. First, in the dog (unpublished 
observations), as in several other species including hu- 
mans (4) but excluding rat (l4), the adrenals contain 
high levels of GLIR. Second, BTSNS clearly activates 
neural input to the adrenal, evidenced by the robust EPI 
response 
Wheth 
observed i 
.er derived 
.n the 
from 
present study. 
gut nerves or the adrenals or 
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both, the increase of circulating GLIR seen during 
BTSNS also raised the question of whether galanin could 
act as a circulating hormone, contributing to the changes 
of pancreatic hormone release observed during BTSNS. 
To address this question, synthetic galanin was infused 
at a rate that reproduced the BTSNS-induced increase 
of arterial GLIR. During these matched infusions, the 
output of IRI was marginally inhibited, glucose levels 
increased modestly, and IRG output tended to increase 
(data not shown). Thus, under some circumstances, pos- 
sibly severe stress, galanin may contribute to humoral 
regulation of islet function. However, it must be allowed 
that the halothane-anesthetized laparotomized dogs are 
inherently stressed, judging by the high “basal” EPI 
levels observed (730 pg/ml, Fig. 3) that were markedly 
lower in the presence of HEX (70 pg/ml, Fig. 7). Because 
we could detect no galanin-sized GLIR in the “basal” 
state before BTSNS (Fig. Z), an endocrine function for 
galanin during mild stress seems unlikely, and even 
during severe stress such as that reproduced by BTSNS, 
a hormonal role would appear quantitatively less impor- 
tant than galanin’s putative role as a local sympathetic 
neurotransmitter. 
In summary, an increasing body of evidence suggests 
that galanin is a sympathetic neurotransmitter in the 
endocrine pancreas of the dog. 1) Galanin is present in 
islet nerves (7). 2) Galanin can exert potent, direct, 
sympathomimetic effects on the endocrine pancreas (7, 
17). 3) There are receptors for galanin on insulin-secret- 
ing cell lines (16). 4) Galanin is released from pancreatic 
nerves in quantities sufficient to inhibit insulin and 
somatostatin and to stimulate glucagon release (10). 
Finally, as suggested by the present studies, 5) there 
exists a local mechanism to terminate galanin’s actions, 
consistent with a role as a local neurotransmitter, and 6) 
sympathetic nerves of the pancreas release galanin. Fur- 
ther studies are needed to determine the physiological or 
pathophysiological conditions under which pancreatic 
galaninergic nerves are activated and to definitively es- 
tablish galanin’s role by blocking the actions of endoge- 
nous galanin under those conditions. 
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